Andere talen Chiome Bioscience Inc.

Aandelen

4583

JP3205350006

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
123 ^JPY	0,00%		-3,15%	-8,89%

13/02	Chiome Bioscience Inc. kondigt een vertrouwensovereenkomst aan met Takeda Pharmaceutical Company Limited	CI
13/02	Chiome Bioscience Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Chiome Bioscience Cancels License Agreements with ADC Therapeutics	01/04
Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited	13/02
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/02
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	14/11
Chiome Bioscience Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	09-08-23
Chiome Bioscience Inc. announced that it has received ¥13.49304 million in funding from Barclays Bank PLC (Tokyo Branch), Growth Capital, Inc.	20-07-23
Chiome Bioscience Inc. announced that it expects to receive Â¥13.49304 million in funding	04-07-23
Chiome Bioscience Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11-05-23
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14-02-23
Chiome Bioscience Inc. Provided Sales Guidance for 2023	14-02-23
Henlius Biotech Terminates License Agreement for Chiome Bioscience's Tumor Drug	17-01-23
Chiome Bioscience Inc. Announces Termination of the License Agreement for Anti-TROP-2 Antibody Development and Commercialization with Shanghai Henlius Biotech, Inc	17-01-23
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	14-11-22
Chiome Bioscience Reports Results of Cancer Immunotherapy Joint Research	09-09-22
Chiome Bioscience Signs Research and Option Agreement with Heidelberg Pharma	14-07-22
Heidelberg Pharma Enters Research Collaboration Deal With Japan's Chiome Bioscience	13-07-22
Chiome Bioscience : Announcement of target-specific research and option agreement with Heidelberg Pharma	13-07-22
Chiome Bioscience Inc. Announces Conclusion of Target-Specific Research and Option Agreement with Heidelberg Pharma	13-07-22
Japan Index Snaps Three-day Winning Streak on Inflationary Pressures; Kudan Shares Expand 7%	12-07-22
Chiome Bioscience, Rohto Pharmaceutical Sign Deal for Generation of Therapeutic Antibody	12-07-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Chiome Bioscience Inc.

Aandelen

4583

JP3205350006

Andere talen

Filters